Profil
Gregory C.
Williams served as Chief Executive Officer & Director at Eloxx Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Chief Development Officer at Radius Health, Inc. from 2014 to 2018.
He also held positions as VP-Regulatory Affairs & Clinical Development at The Medicines Co. from 2006 to 2013 and as Vice President-Regulatory Affairs & Compliance at NPS Pharmaceuticals, Inc. from 2004 to 2006.
Williams holds a doctorate from Rutgers State University of New Jersey and an MBA from Cornell University.
Anciens postes connus de Gregory Williams
| Sociétés | Poste | Fin |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Directeur Général | 01/04/2021 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 25/05/2018 |
| THE MEDICINES COMPANY | Directeur Technique/Scientifique/R&D | 01/01/2013 |
| NPS PHARMACEUTICALS, INC. | Compliance Officer | 01/01/2006 |
Formation de Gregory Williams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
















